35+ year pan-Asia VC investing in healthcare, biotech, AI, and deep tech. Singapore-based with global reach. Backed UCARE.AI Series A — a direct comparable to MOVO-X.
Walden International led the Series A of UCARE.AI — a hospital AI platform that is the closest public comparable to MOVO-X. That investment history demonstrates Walden understands the hospital AI market, the sales cycle, the clinical validation requirements, and the enterprise deployment complexity. MOVO-X is the next UCARE.AI, with a broader geographic footprint and a more comprehensive platform covering kiosk, queue, triage, and data.
Malaysia's largest private hospital group. Bursa-listed. JCorp majority. 30+ hospitals across 13 Malaysian states. Advanced discussions underway — significant potential for enterprise-wide AI triage, queue management, and kiosk check-in deployment.
Multi-tenant SaaS active across Quebec and Ontario clinic networks. PIPEDA + Law 25 compliant. Interac and Stripe payments. Architecture validated across clinic groups.
Full PDPA (SG), HBRA, and NEHR integration architecture complete. PayNow + NETS + Stripe. English and Mandarin. Strong pipeline potential with Singapore hospital groups.
We'd love to walk you through our product, architecture, and pipeline. If healthcare AI in ASEAN fits your mandate, we should have a conversation.